IBDEI058 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2153,2)
 ;;=^335281
 ;;^UTILITY(U,$J,358.3,2154,0)
 ;;=533.90^^21^187^29
 ;;^UTILITY(U,$J,358.3,2154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2154,1,4,0)
 ;;=4^533.90
 ;;^UTILITY(U,$J,358.3,2154,1,5,0)
 ;;=5^Peptic Ulcer w/o Obstruc
 ;;^UTILITY(U,$J,358.3,2154,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,2155,0)
 ;;=533.91^^21^187^28
 ;;^UTILITY(U,$J,358.3,2155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2155,1,4,0)
 ;;=4^533.91
 ;;^UTILITY(U,$J,358.3,2155,1,5,0)
 ;;=5^Peptic Ulcer w/ Obstruction
 ;;^UTILITY(U,$J,358.3,2155,2)
 ;;=^270138
 ;;^UTILITY(U,$J,358.3,2156,0)
 ;;=070.54^^21^187^7
 ;;^UTILITY(U,$J,358.3,2156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2156,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,2156,1,5,0)
 ;;=5^Chr Hep C w/o Coma
 ;;^UTILITY(U,$J,358.3,2156,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,2157,0)
 ;;=V02.62^^21^187^21
 ;;^UTILITY(U,$J,358.3,2157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2157,1,4,0)
 ;;=4^V02.62
 ;;^UTILITY(U,$J,358.3,2157,1,5,0)
 ;;=5^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,2157,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,2158,0)
 ;;=583.9^^21^188^7
 ;;^UTILITY(U,$J,358.3,2158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2158,1,4,0)
 ;;=4^583.9
 ;;^UTILITY(U,$J,358.3,2158,1,5,0)
 ;;=5^Glomerulonephritis
 ;;^UTILITY(U,$J,358.3,2158,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,2159,0)
 ;;=581.9^^21^188^9
 ;;^UTILITY(U,$J,358.3,2159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2159,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,2159,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,2159,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,2160,0)
 ;;=753.12^^21^188^13
 ;;^UTILITY(U,$J,358.3,2160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2160,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,2160,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,2160,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,2161,0)
 ;;=596.0^^21^188^3
 ;;^UTILITY(U,$J,358.3,2161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2161,1,4,0)
 ;;=4^596.0
 ;;^UTILITY(U,$J,358.3,2161,1,5,0)
 ;;=5^Bladder Neck Obstruction
 ;;^UTILITY(U,$J,358.3,2161,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,2162,0)
 ;;=788.1^^21^188^5
 ;;^UTILITY(U,$J,358.3,2162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2162,1,4,0)
 ;;=4^788.1
 ;;^UTILITY(U,$J,358.3,2162,1,5,0)
 ;;=5^Dysuria
 ;;^UTILITY(U,$J,358.3,2162,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,2163,0)
 ;;=604.90^^21^188^12
 ;;^UTILITY(U,$J,358.3,2163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2163,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,2163,1,5,0)
 ;;=5^Orchitis/Epididymit
 ;;^UTILITY(U,$J,358.3,2163,2)
 ;;=^86178
 ;;^UTILITY(U,$J,358.3,2164,0)
 ;;=788.30^^21^188^18
 ;;^UTILITY(U,$J,358.3,2164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2164,1,4,0)
 ;;=4^788.30
 ;;^UTILITY(U,$J,358.3,2164,1,5,0)
 ;;=5^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,2164,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,2165,0)
 ;;=596.54^^21^188^10
 ;;^UTILITY(U,$J,358.3,2165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2165,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,2165,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,2165,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,2166,0)
 ;;=788.43^^21^188^11
 ;;^UTILITY(U,$J,358.3,2166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2166,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,2166,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,2166,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,2167,0)
 ;;=590.00^^21^188^14
 ;;^UTILITY(U,$J,358.3,2167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2167,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,2167,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,2167,2)
 ;;=^270367
